Unformatted text preview: • – Nocturnal symptoms • – History of ICU admission • – Mechanical ventilation • – More than two hospitalizations per year • – Systemic steroid dependence • – History of syncope with asthma • Mortality rates are increasing. If response to treatment is poor, review diagnosis and compliance prior to adding more potent therapy PATIENT MONITORING • Peak expiratory flow rate at home: Record for trend; call if < 70% baseline, ER if < 50% baseline. • pH and arterial blood gases • Oximetry with status asthmatics • Electrolytes: Frequent albuterol lowers potassium. • Written and periodically revised action plan is helpful. Review metered-dose inhaler technique periodically...
View Full Document
- Spring '14
- Montelukast, High-dose inhaled steroids, Diagnoses & Therapeutics III: RESPIRATORY DISORDERS TREATMENT